• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention.

作者信息

Theoret Marc R, Ning Yang-Min, Zhang Jenny J, Justice Robert, Keegan Patricia, Pazdur Richard

机构信息

Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.

出版信息

N Engl J Med. 2011 Jul 14;365(2):97-9. doi: 10.1056/NEJMp1106783. Epub 2011 Jun 15.

DOI:10.1056/NEJMp1106783
PMID:21675880
Abstract
摘要

相似文献

1
The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention.5α还原酶抑制剂用于前列腺癌预防的风险与益处。
N Engl J Med. 2011 Jul 14;365(2):97-9. doi: 10.1056/NEJMp1106783. Epub 2011 Jun 15.
2
Role of 5α-reductase inhibitors in prostate cancer prevention and treatment.5α-还原酶抑制剂在前列腺癌防治中的作用。
Urology. 2012 Jun;79(6):1197-205. doi: 10.1016/j.urology.2012.01.024. Epub 2012 Mar 23.
3
Do no harm: a case in point.切勿伤害：一个恰当的例子。
Perspect Biol Med. 2012;55(2):291-8. doi: 10.1353/pbm.2012.0012.
4
Preventing prostate cancer: new analyses put finasteride back on the map.预防前列腺癌：新分析使非那雄胺再度受到关注。
J Natl Cancer Inst. 2008 Aug 20;100(16):1132-3. doi: 10.1093/jnci/djn300. Epub 2008 Aug 11.
5
Dutasteride for the treatment of prostate-related conditions.度他雄胺治疗前列腺相关疾病。
Expert Opin Drug Saf. 2012 Mar;11(2):325-30. doi: 10.1517/14740338.2012.658040. Epub 2012 Feb 8.
6
Therapeutic hotline. Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?治疗热线。用非那雄胺治疗雄激素性脱发可能会导致患者的前列腺癌等级升高：这是事实还是虚构？
Dermatol Ther. 2010 Sep-Oct;23(5):544-6. doi: 10.1111/j.1529-8019.2010.01358.x.
7
Dutasteride: high-grade prostate cancer. Risky in prostate cancer prevention.度他雄胺：高级别前列腺癌。在前列腺癌预防中存在风险。
Prescrire Int. 2011 Nov;20(121):267.
8
Prostate cancer chemoprevention with 5α-reductase inhibitors.5α-还原酶抑制剂用于前列腺癌化学预防
Urol Oncol. 2012 Sep;30(5):553-4. doi: 10.1016/j.urolonc.2011.02.006.
9
The utility of 5-alpha reductase inhibitors in the prevention and diagnosis of prostate cancer.5-α还原酶抑制剂在前列腺癌预防和诊断中的效用。
Curr Opin Urol. 2009 May;19(3):238-42. doi: 10.1097/MOU.0b013e328329eb29.
10
Few physicians prescribe 5-alpha reductase inhibitors for prostate cancer prevention.很少有医生会开5-α还原酶抑制剂来预防前列腺癌。
CA Cancer J Clin. 2011 Jan-Feb;61(1):1-2. doi: 10.3322/caac.20100. Epub 2011 Jan 3.

引用本文的文献

1
Periprostatic adipose tissue inhibits tumor progression by secreting apoptotic factors: A natural barrier induced by the immune response during the early stages of prostate cancer.前列腺周围脂肪组织通过分泌凋亡因子抑制肿瘤进展：前列腺癌早期由免疫反应诱导的天然屏障。
Oncol Lett. 2024 Aug 8;28(4):485. doi: 10.3892/ol.2024.14617. eCollection 2024 Oct.
2
Five-alpha reductase inhibitors and risk of prostate cancer among men with benign prostatic hyperplasia: A historical cohort study using primary care data.5α还原酶抑制剂与良性前列腺增生男性患前列腺癌的风险：一项利用初级保健数据的历史性队列研究。
Wellcome Open Res. 2023 Jul 11;8:295. doi: 10.12688/wellcomeopenres.19566.1. eCollection 2023.
3
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors.
应用 5α-还原酶抑制剂治疗的男性患者中，应用磁共振成像进行前列腺癌诊断。
World J Urol. 2023 Nov;41(11):2967-2974. doi: 10.1007/s00345-023-04634-2. Epub 2023 Oct 3.
4
Opportunities for Achieving the Cancer Moonshot Goal of a 50% Reduction in Cancer Mortality by 2047.实现癌症登月计划目标的机会，即在 2047 年将癌症死亡率降低 50%。
Cancer Discov. 2023 May 4;13(5):1084-1099. doi: 10.1158/2159-8290.CD-23-0208.
5
5-Alpha Reductase Inhibitors and Prostate Cancer Mortality among Men with Regular Access to Screening and Health Care.5α-还原酶抑制剂与有定期筛查和医疗保健可及性的男性前列腺癌死亡率。
Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1460-1465. doi: 10.1158/1055-9965.EPI-21-1234.
6
Cancer Prevention and Screening for Older Adults: Part 2. Interventions to Prevent and Screen for Breast, Prostate, Cervical, Ovarian, and Endometrial Cancer.老年人癌症预防和筛查：第 2 部分。预防和筛查乳腺癌、前列腺癌、宫颈癌、卵巢癌和子宫内膜癌的干预措施。
J Am Geriatr Soc. 2020 Nov;68(11):2684-2691. doi: 10.1111/jgs.16794. Epub 2020 Sep 3.
7
Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer.5α-还原酶抑制剂治疗与前列腺癌诊断和死亡时间的关系。
JAMA Intern Med. 2019 Jun 1;179(6):812-819. doi: 10.1001/jamainternmed.2019.0280.
8
Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia.曲氟尿苷四氟铝酸盐治疗男性良性前列腺增生相关下尿路症状的门诊疗效与安全性。
Ther Adv Urol. 2019 Jan 14;11:1756287218820807. doi: 10.1177/1756287218820807. eCollection 2019 Jan-Dec.
9
Prevention of prostate cancer by natural product MDM2 inhibitor GS25: in vitro and in vivo activities and molecular mechanisms.天然产物 MDM2 抑制剂 GS25 预防前列腺癌：体外和体内活性及分子机制。
Carcinogenesis. 2018 Jul 30;39(8):1026-1036. doi: 10.1093/carcin/bgy063.
10
Revisiting 5α-reductase inhibitors and the risk of prostate cancer.重新审视 5α-还原酶抑制剂与前列腺癌风险。
Nat Rev Urol. 2018 Jul;15(7):400-401. doi: 10.1038/s41585-018-0018-9.